Lupin Limited
LUPIN
Pozycja w akcjach
#2105
Lupin Limited is a pharmaceutical firm dedicated to the creation,... Lupin Limited is a pharmaceutical firm dedicated to the creation, manufacturing, commercialization, and distribution of a wide array of branded and generic medications, biotechnology items, and active pharmaceutical ingredients (APIs). Its comprehensive product portfolio addresses diverse therapeutic categories, including cardiovascular health, diabetes management, asthma, pediatric care, central nervous system disorders, gastrointestinal issues, anti-infectives, nonsteroidal anti-inflammatory drug (NSAID) therapy, respiratory ailments, women's health, and anti-tuberculosis treatments. Beyond its primary offerings, Lupin also supplies biosimilars and over-the-counter (OTC) medicines, alongside specialized pharmaceutical products. The company actively pursues drug discovery and development initiatives focused on oncology, immunology, and metabolic disorders, complementing these efforts with bio-clinical research. Lupin Limited maintains an extensive operational network comprising 18 laboratories, 280 LupiMitra collection centers, and 450 pick-up points. Its global presence extends across numerous countries, such as India, the United States, the United Kingdom, South Africa, Australia, the Philippines, Germany, the Netherlands, Mexico, and Brazil. Originally named Lupin Chemicals Limited, the company adopted its current identity, Lupin Limited, in 2001 following its merger with Lupin Laboratories Limited. Established in 1968, Lupin Limited is based in Mumbai, India.
Cena akcji
$21.30
Ostatnia synchronizacja: 2026-10-19
Kapitalizacja rynkowa
$9.74B
Zmiana (1 dzień)
-1.83%
Zmiana (1 rok)
-3.70%
Kraj
IN
Handel Lupin Limited (LUPIN)
Kategoria
Healthcare
EPS dla Lupin Limited (LUPIN)
EPS na dzień June 2026 TTM: $1.34
Według najnowszych raportów finansowych i ceny akcji firmy Lupin Limited, obecny EPS (TTM) wynosi $1.34. Na koniec roku 2024 firma miała EPS w wysokości $0.50, wzrost w porównaniu do do EPS z roku 2023, który wynosił $0.12.
Historia EPS dla Lupin Limited od 2004 do 2026
EPS na koniec każdego roku
| Rok | EPS | Zmień |
|---|---|---|
| 2026 (TTM) | $1.34 | 58.99% |
| 2025 | $0.84 | 66.83% |
| 2024 | $0.50 | 338.14% |
| 2023 | $0.12 | -125.96% |
| 2022 | $-0.44 | -220.92% |
| 2021 | $0.37 | -413.07% |
| 2020 | $-0.12 | -171.84% |
| 2019 | $0.16 | 90.87% |
| 2018 | $0.09 | -90.23% |
| 2017 | $0.87 | 15.30% |
| 2016 | $0.76 | -11.63% |
| 2015 | $0.86 | -3.94% |
| 2014 | $0.89 | 65.13% |
| 2013 | $0.54 | 41.15% |
| 2012 | $0.38 | -11.79% |
| 2011 | $0.43 | 23.16% |
| 2010 | $0.35 | 47.14% |
| 2009 | $0.24 | -4.08% |
| 2008 | $0.25 | 43.29% |
| 2007 | $0.17 | 84.16% |
| 2006 | $0.09 | 84.60% |
| 2005 | $0.05 | 7.55% |
| 2004 | $0.05 | 0.00% |
EPS dla podobnych firm lub konkurentów
| Firma | EPS | Różnica w EPS | Kraj |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -58.35% |
IN
|
